NCT02103361View on ClinicalTrials.gov

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2030

Study Completion Date

February 28, 2031

Conditions

PsoriasisPregnancyPsoriatic ArthritisCrohn Disease

Interventions

DRUG

Ustekinumab

DRUG

Guselkumab

Trial Locations (1)

92093

RECRUITING

University of California, San Diego, La Jolla

Sponsors

Collaborators (1)

Janssen Biotech, Inc.

All Listed Sponsors

collaborator

The Organization of Teratology Information Specialists

OTHER

collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

University of California, San Diego

OTHER

NCT02103361 - Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project | Biotech Hunter | Biotech Hunter